Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cycloserine for extinction of alcohol cue-conditioned responses
2006-007090-72Phase 2Active
- Sponsor
- Central Institute of Mental Health
- Start
- Jul 2007
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, single-arm trial of d-cycloserine in alcohol dependence, sponsored by Central Institute of Mental Health. Primary endpoints: Extinction of conditioned reactions toward alcohol cues measured by dot-probe task and Neural correlates of extinction of conditioned alcohol cue responses by fMRI. Started Jul 2007; status: active.
02
Drugs
d-cycloserine
03
Conditions
alcohol dependence
Beyond the preview
Go deeper on 2006-007090-72.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-007090-72.